Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00200785 · ClinicalTrials.gov registry record · NA
Identifying the Anti-Blood-Clotting Compounds in Garlic
A NA study, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- Completed
- Registry status
- NA
- Development phase
- 9
- Enrollment target
NCT00200785: Completed NA study, sponsored by National Center for Complementary and Integrative Health (NCCIH).
NCT00200785 is a NA study that has completed, run by National Center for Complementary and Integrative Health (NCCIH). The registered enrollment target is 9 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00200785, a NA study, has completed, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- COMPLETED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
Study Summary
This study will seek to identify the compound(s) in garlic that is (are) responsible for its ability to prevent the formation of blood clots (prevent platelet aggregation) and to determine the maximally effective dose and duration of the benefits. This study will also determine whether "cooked" garlic (garlic powder added to boiling water, no allicin present) is as effective as "fresh" garlic (garlic powder added to ambient water, high allicin present) and, if more than one compound is involved, and whether their combined effects are more significant than the effects of each compound alone.
Primary Outcome
percent platelet aggregation in collagen-induced platelet aggregation in platelet rich plasma (PRP)
Interventions
- DIETARY_SUPPLEMENT garlic powder added to ambient water
- DIETARY_SUPPLEMENT garlic powder added to boiling water
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2006-03 |
| Est. Completion | 2007-09 |
| Phase | NA |
What the finished NCT00200785 record still lists
NCT00200785 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which garlic powder added to ambient water is the first listed.
NCT00200785 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00200785 about?
NCT00200785 is a clinical study titled "Identifying the Anti-Blood-Clotting Compounds in Garlic". This study will seek to identify the compound(s) in garlic that is (are) responsible for its ability to prevent the formation of blood clots (prevent platelet aggregation) and to determine the maximally effective dose and duration of the benefits. This study will also determine whether "cooked" garl...
What is the current status of trial NCT00200785?
This trial is currently completed. It is a NA study. The enrollment target is 9 participants. The study started on 2006-03. Estimated completion is 2007-09.
What interventions are being tested in trial NCT00200785?
The interventions under investigation include: garlic powder added to ambient water (DIETARY_SUPPLEMENT), garlic powder added to boiling water (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00200785?
This trial is sponsored by National Center for Complementary and Integrative Health (NCCIH), which has 203 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00200785's enrollment target sits among peer trials
9 1975th of 2000 higher than 25 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia